Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma

Summary

RATIONALE: Current therapies for adult recurrent/progressive low grade astrocytoma provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of adult recurrent/progressive low grade astrocytoma. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on adults with a recurrent/progressive low grade astrocytoma.

Timeline

Start

1996-03

Primary completion

2003-07

Completion

2003-07

Drugs

Indications